WASHINGTON, Jan 16 (Reuters) – Australian company CSL Ltd
(
CSL.AX
) won U.S. approval on Friday to sell an intravenous
treatment for a bleeding disorder seen in patients with a rare
genetic defect.
The Food and Drug Administration cleared the product,
Riastap, for people with congenital fibrinogen deficiency. The
disorder limits the blood’s ability to clot and puts patients
at risk of life-threatening bleeding without treatment, the FDA
said. Read the rest of this entry »
Last year, results from the
, aggressive
was just as effective as angioplasty and stenting at preventing heart attacks and death. The trial created quite a stir within the cardiology community, a community that tends to really like
.
Cardiologists reluctant to cut back on stenting told themselves – and their patients – that even if the COURAGE trial was correct, there was still a reason to prefer stents over medical therapy, namely, that stenting Read the rest of this entry »
Tuesday, October 14, 2008
I’VE NOTICED that a new drug treatment for stroke has been mentioned in the media recently. Can you tell me what it’s called and how does it work?
The treatment you refer to has several names including thrombolytic therapy and, more commonly, clot-busting treatment. This therapy involves the use of drugs to break up or dissolve blood clots, the main cause of stroke and heart attack.
When a blood clot forms, it can move Read the rest of this entry »
Six years after landmark research uncovered breast cancer risk in the nation’s most popular menopause treatment, two new Stanford University analyses show that using long-term hormone replacement therapy poses a far greater risk of cancer than previously thought.
The research concludes that a woman who stays on the therapy for at least five years doubles her risk of breast cancer every year. This sharply elevated risk is much greater than the 27 Read the rest of this entry »
A study has concluded that one dose of chemotherapy is the best way to cure testicular cancer in many patients.
Doctors already offer either carboplatin or radiotherapy, but scientists needed long-term trial results to see which was the best.
The Medical Research Council project found that the drug offered a similar relapse rate – but far fewer side effects.
A leading expert said it could one day reduce the need for testicle removal.
Several Read the rest of this entry »
New York, NY
(NBC) — The Food and Drug Administration has cleared the way for the first-ever human trial of a medical treatment, derived from embryonic stem cells.
The company plans to start testing this embryonic stem cell therapy on patients with spinal cord injuries.
Members of one spinal cord injury peer support group are buzzing about Menlo Park Company’s efforts to use embryonic stem cell therapy on people with spinal cord injuries. Read the rest of this entry »
(RTTNews) -
Competitive Technologies Inc. (CTT:
) announced that the US Federal Drug Administration has issued a 501(k) letter of authorization allowing US sales of CTT’s pain therapy medical device.
The device is a non-invasive method for rapid treatment of high-intensity oncologic and neuropathic pain, including pain resistant to morphine and other drugs. CTT has exclusive worldwide rights to this patented device. Read the rest of this entry »
Monday, January 26, 2009
A drive to bring cooling therapy to heart attack victims in Palm Beach County is only in the embryonic stage.
But representatives of hospitals used by Palm Beach residents say they are, at least, studying the issue. And St. Mary’s Medical Center is using therapeutic hypothermia for post-cardiac arrest patients.
The American Heart Association in 2003 advised the medical community to provide therapeutic hypothermia Read the rest of this entry »
if they take hormone replacement therapy (called HRT for short). But not all studies show this.
. This means doctors don’t usually choose it first for treating osteoporosis.
).
). The studies compared HRT with other treatments or no treatment in women who had been through the menopause. The studies involved many thousands of women in all.
Two of the summaries showed that women who had gone through the menopause were less likely to break a Read the rest of this entry »
The number of breast cancer cases in the United States dropped markedly after women quit combination hormones for postmenopausal symptoms in droves in the early part of this decade, according to a paper published today in The New England Journal of Medicine.
Investigators also found that taking estrogen plus progestin for five years doubled a women’s chances of developing breast cancer — the most detailed indication yet that the cancer risks Read the rest of this entry »